MAUDE MDR 8166656

MDR report key
8166656
Report number
8030965-2018-59050
Event key
0
Event type
3
Date of event
2018-11-28
Date received
2018-12-14
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
0
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
MS. KARA DITTY-BOVARD
Address
EIMATTSTRASSE 3 OBERDORF 4436 SZ
Phone
610-610-6103
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1DOUBLEAIRHOSE L5M F/SYST SYNTHESINSTRUMENT SURGICAL, ORTHO, PNEUMATIC, POWERED AND ACCESSORY/ATTACHMENTDEPUY SYNTHES PRODUCTS LLCHSZ519.530N/IR N

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12018-12-140

Event Narratives#

N

Patient 1

DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. UDI: LOT/SERIAL UNKNOWN. (B)(4). DEVICE MANUFACTURE DATE: THE DEVICE MANUFACTURE DATE IS UNAVAILABLE. THE MANUFACTURING LOCATION WAS UNKNOWN. AS OF THIS DATE, THE DEVICE HAS NOT BEEN RETURNED FOR EVALUATION; THEREFORE, THE REPORTED CONDITION CANNOT BE CONFIRMED AND/OR DUPLICATED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

D

Patient 1

IT WAS REPORTED FROM (B)(6) THAT DURING A OSTEOSYNTHESIS SURGICAL PROCEDURE FOR THE FEMORAL TROCHANTERIC FRACTURE WITH TFN-ADVANCED PROXIMAL FEMORAL NAILING SYSTEM (TFNA) AND COMPACT AIR DRIVE (CAD) DEVICE IT WAS OBSERVED THAT THE DOUBLE AIR HOSE DEVICE RUPTURED, AND THE CAD WAS UNABLE TO BE USED FOR DRILLING. IT WAS REPORTED THAT THE PROCEDURE WAS COMPLETED SUCCESSFULLY BY USING AN UNSPECIFIED SPARE POWER TOOL (ZIMMER DEVICE) IN THE HOSPITAL. IT WAS REPORTED THAT THERE WAS A LESS THAN 30-MINUTE DELAY IN THE PROCEDURE DUE TO THE EVENT. THERE WAS PATIENT INVOLVEMENT REPORTED. THERE WERE NO REPORTS OF INJURIES, MEDICAL INTERVENTION OR PROLONGED HOSPITALIZATION. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. IF ADDITIONAL INFORMATION SHOULD BECOME AVAILABLE, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED ACCORDINGLY.